It is published in the April 21, 2005, edition of the brand new England Journal of Medicine. Many previous studies have found the bacteria Chlamydia pneumoniae in the arterial plaque of sufferers with coronary artery disease. This led to the investigation of whether antibiotics could be used to treat the bacteria and therefore reduce the risk of cardiac events. Approximately 50 % of U.S. Adults have been exposed to C. Pneumoniae at some time in their lives. It spreads through the air and can cause pneumonia. This study found no benefit from dealing with the C. Pneumoniae bacterias with antibiotic in order to reduce the risk of coronary attack or improve overall cardiac outcomes, stated NHLBI Director Elizabeth G.Domainex also provides extensive chemistry providers to biotech and pharmaceutical companies involved in medication discovery through its subsidiary NCE Discovery, which includes laboratories on the Cambridge Technology Park, and is handled by Study Director, Dr Trevor Perrior, an extremely experienced scientist who offers been in charge of the discovery of many medicines. THE BUSINESS plans to utilize the new funding to build up its CDH technology and NCE Discovery chemistry providers businesses.